Antiinflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery

被引:15
作者
Hamada, Y [1 ]
Kawachi, K [1 ]
Nakata, T [1 ]
Kohtani, T [1 ]
Takano, S [1 ]
Tsunooka, N [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Surg 2, Shigenobu, Ehime 7910295, Japan
关键词
open heart surgery; coronary artery bypass surgery; cardiopulmonary bypass; inflammatory response;
D O I
10.1046/j.1525-1594.2001.06754.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Cardiac surgery with cardiopulmonary bypass is associated with a systemic inflammatory response. We examined combined use of heparin coating of the cardiopulmonary bypass circuit and a leukocyte-depleting arterial line filter to reduce this response. Thirty patients were allocated randomly to equal groups with a conventional circuit and arterial line filter (C group), a heparin-coated circuit with a conventional filter (H group), or a heparin-coated circuit with a leukocyte-depleting arterial line filter (HF group). Cytokines and respiratory function were repeatedly measured perioperatively. Plasma interleukin (IL)-6 concentrations in the HF group were lower than in the C group immediately following bypass and operation, at 4 h, and 12 h (p < 0.05). Plasma IL-8 was lower in the HF group than in the C group at 4 h (p < 0.05). The respiratory index was lower immediately after bypass in the HF group than the C group (0.61 +/- 0.2 versus 1.05 +/- 0.4, p < 0.05). Heparin-coated circuits with leukocyte-depleting filters decrease inflammatory responses and improve pulmonary function during operation.
引用
收藏
页码:1004 / 1008
页数:5
相关论文
共 23 条
[1]   OUR EXPERIENCE WITH USING THE PALL LG6 LEUKOCYTE DEPLETING FILTER DURING CARDIOPULMONARY BYPASS [J].
ALEBRAHIM, K ;
SHAFEI, H .
ANNALS OF THORACIC SURGERY, 1993, 56 (05) :1216-1217
[2]   Leucocyte depletion in cardiothoracic surgery [J].
Allen, S. M. .
PERFUSION-UK, 1996, 11 (03) :270-277
[3]   Inflammatory response after coronary revascularization with or without cardiopulmonary bypass [J].
Ascione, R ;
Lloyd, CT ;
Underwood, MJ ;
Lotto, AA ;
Pitsis, AA ;
Angelini, GD .
ANNALS OF THORACIC SURGERY, 2000, 69 (04) :1198-1204
[4]  
BANDO K, 1990, J THORAC CARDIOV SUR, V99, P873
[5]  
BOONSTRA PW, 1994, J THORAC CARDIOV SUR, V107, P289
[6]   Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury [J].
Boyle, EM ;
Kovacich, JC ;
Hèbert, CA ;
Canty, TG ;
Chi, E ;
Morgan, EN ;
Pohlman, TH ;
Verrier, ED .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (01) :114-120
[7]   INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS [J].
BUTLER, J ;
ROCKER, GM ;
WESTABY, S .
ANNALS OF THORACIC SURGERY, 1993, 55 (02) :552-559
[8]   Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration [J].
Defraigne, JO ;
Pincemail, J ;
Larbuisson, R ;
Blaffart, F ;
Limet, R .
ANNALS OF THORACIC SURGERY, 2000, 69 (04) :1084-1091
[9]   Inflammatory response to cardiopulmonary bypass [J].
Edmunds, LH .
ANNALS OF THORACIC SURGERY, 1998, 66 (05) :S12-S16
[10]   Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes in fully heparinized patients: A European multicentre study [J].
Fosse, E ;
Thelin, S ;
Svennevig, JL ;
Jansen, P ;
Mollnes, TE ;
Hack, E ;
Venge, P ;
Moen, O ;
Brockmeier, V ;
Dregelid, E ;
Halden, E ;
Hagman, L ;
Videm, V ;
Pedersen, T ;
Mohr, B .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (02) :320-327